Thursday, October 27, 2016: 11:00 AM-12:00 PM
Room: 391-392
Learning Objectives:
At the conclusion of this session, participants will be able to:
- apply knowledge presented by the speakers relating to laboratory investigations of respiratory viral pathogenesis to clinical practice
- summarize information presented by the speakers relating to outcomes of laboratory investigations of respiratory viral pathogenesis to concepts pertaining to vaccine development
- recognize the contributions of Caroline B. Hall to the field of respiratory viral immunopathogenesis and acknowledge the support of investigators who continue her notable work
Target Audience: Academicians, Clinicians, Epidemiologists, Fellows, Healthcare workers, Hospital epidemiologists, Infection preventionists, Infectious diseases pediatricians, Infectious diseases physicians, Investigators, Lab personnel, Members-in-training, Microbiologists, Researchers, Scientists, Vaccinologists
Tracks: Investigative ID, Pediatric ID
Moderator:
John V. Williams, MD, Children's Hospital of Pittsburgh and University of Pittsburgh School of Medicine
Presentations:
CME Credits: Maximum of 1 hours of AMA PRA Category 1 Credit™
ACPE Credits:
ACPE Number:
Disclosures:
J. V. Williams,
Quidel:
Scientific Advisor
,
Consulting fee
GlaxoSmithKline:
Scientific Advisor
,
Consulting fee
Merck:
Consultant
,
Consulting fee
See more of: Named Lecture